BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 7563086)

  • 1. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
    Daly TJ; Doten RC; Rusche JR; Auer M
    J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
    Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
    Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
    Nam YS; Petrovic A; Jeong KS; Venkatesan S
    J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural dynamics of HIV-1 Rev and its complexes with RRE and 5S RNA.
    Lam WC; Seifert JM; Amberger F; Graf C; Auer M; Millar DP
    Biochemistry; 1998 Feb; 37(7):1800-9. PubMed ID: 9485305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural change in Rev responsive element RNA of HIV-1 on binding Rev peptide.
    Peterson RD; Feigon J
    J Mol Biol; 1996 Dec; 264(5):863-77. PubMed ID: 9000617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding kinetics and bioassay of RRE mRNA fragments to a peptide containing the recognition domain of HIV-1 Rev.
    West ML; Ramsdale TE
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):85-8. PubMed ID: 9575345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dynamic in vivo view of the HIV-I Rev-RRE interaction.
    Charpentier B; Stutz F; Rosbash M
    J Mol Biol; 1997 Mar; 266(5):950-62. PubMed ID: 9086273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
    Luedtke NW; Tor Y
    Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of HIV Rev peptides with the Rev response element RNA.
    Williamson JR; Battiste JL; Mao H; Frankel AD
    Nucleic Acids Symp Ser; 1995; (33):46-8. PubMed ID: 8643394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region.
    Wang Y; Hamasaki K; Rando RR
    Biochemistry; 1997 Jan; 36(4):768-79. PubMed ID: 9020774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perturbation of the carboxy terminus of HIV-1 Rev affects multimerization on the Rev responsive element.
    Daly TJ; Rennert P; Lynch P; Barry JK; Dundas M; Rusche JR; Doten RC; Auer M; Farrington GK
    Biochemistry; 1993 Aug; 32(34):8945-54. PubMed ID: 8364040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted cleavage of HIV rev response element RNA by metallopeptide complexes.
    Jin Y; Cowan JA
    J Am Chem Soc; 2006 Jan; 128(2):410-1. PubMed ID: 16402818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro.
    Daly TJ; Cook KS; Gray GS; Maione TE; Rusche JR
    Nature; 1989 Dec; 342(6251):816-9. PubMed ID: 2481237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives.
    Ratmeyer L; Zapp ML; Green MR; Vinayak R; Kumar A; Boykin DW; Wilson WD
    Biochemistry; 1996 Oct; 35(42):13689-96. PubMed ID: 8885849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence specificity in the higher-order interaction of the Rev protein of HIV-1 with its target sequence, the RRE.
    Powell DM; Zhang MJ; Konings DA; Wingfield PT; Stahl SJ; Dayton ET; Dayton AI
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):317-23. PubMed ID: 7552493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of the RRE binding and activation domains of the caprine arthritis encephalitis virus Rev protein.
    Schoborg RV; Clements JE
    Virology; 1996 Dec; 226(1):113-21. PubMed ID: 8941328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.